June 23, 2017 Licensing, IP, and Legal PR/Corporate Product Launch

New data at EAN show Roche’s OCREVUS™ (ocrelizumab) significantly reduced multiple measures of disease progression in relapsing and primary progressive multiple sclerosis

Basel, 23 June 2017 New data at EAN show Roche’s OCREVUS™ (ocrelizumab) significantly reduced multiple measures of disease progression in relapsing and primary progressive multiple sclerosis OCREVUS increased the number of patients with relapsing MS (RMS) and primary progressive MS (PPMS) who maintained No Evidence of Progression or Active Disease (NEPAD) versus Rebif (interferon beta-1a)... Read more

June 21, 2017 Licensing, IP, and Legal

Brooks Automation to Participate in the CEO Investor Summit 2017

CHELMSFORD, Mass., June 21, 2017 (GLOBE NEWSWIRE) — Brooks Automation, Inc. (Nasdaq:BRKS) announced today that the Company’s management will participate in the Ninth Annual CEO Investor Summit 2017, on Wednesday, July 12, 2017 in San Francisco, California. About The CEO Investor SummitThe CEO Summit is an accredited investor and publishing research analyst event that is... Read more

June 14, 2017 Lab Top-10 Licensing, IP, and Legal Life Science Tools

MilliporeSigma Awarded its First CRISPR Patent by Australian Patent Office

News Release June 14, 2017 Your Contact: Karen Tiano +1 978-495-0093 MilliporeSigma Awarded its First CRISPR Patent by Australian Patent Office Patent covers successful integration of an external DNA sequence into the chromosome of eukaryotic cells using CRISPR Similar patents pending in other countries; anticipate favorable outcomes Billerica, Massachusetts, June 14, 2017 — MilliporeSigma today announced... Read more

June 13, 2017 Licensing, IP, and Legal Life Science Tools

European Patent Office Confirms Grant of New ICE COLD-PCR Patent Exclusively Licensed to Transgenomic

OMAHA, Neb. (June 13, 2017) — Transgenomic, Inc. (OTCQB: TBIO) today reported that the European Patent Office (EPO) has confirmed its intention to grant a patent covering multiplexed ICE COLD-PCR (MX-ICP) technology in the European Union (EU). This Dana-Farber Cancer Institute patent is exclusively licensed to Transgenomic. Paul Kinnon, President and CEO of Transgenomic, commented,... Read more

June 9, 2017 Clinical Research/Diagn. Licensing, IP, and Legal

Refurbished Parts for GE Diagnostic Imaging Equipment Now Available from GE Healthcare

MILWAUKEE – June 9, 2017 – Demand for quality used parts has increased as hospitals and healthcare systems have become more sophisticated about medical equipment maintenance and management. Now more than 10,000 types of refurbished parts for GE Diagnostic Imaging equipment are available as GoldSeal parts from GE Healthcare. Hospital in-house service departments can find... Read more

June 5, 2017 Chromatography Lab Top-10 Licensing, IP, and Legal Mass Spectrometry

Agilent Technologies Announces Revolutionary Triple Quadrupole Mass Spectrometer

New LC/MS Triple Quadrupole is 70% Smaller Footprint but Equivalent Performance to Larger Instruments SANTA CLARA, Calif., June 5, 2017 Agilent Technologies Inc. (NYSE: A) today, introduced the newest member of its family of triple quadrupole liquid chromatography mass spectrometers (triple quad LC/MS) at the American Society for Mass Spectrometry Conference (ASMS), being held June... Read more

June 5, 2017 Licensing, IP, and Legal Mass Spectrometry

Next-Generation Triple Quadrupole Mass Spectrometers Deliver High Precision for Quantitative Workflows

Analytical laboratories can now obtain high quality data with new triple quadrupole mass spectrometry technology designed to provide exceptional performance for the most demanding targeted quantitation applications in the environmental, food safety, pharmaceutical and biopharmaceutical industries as well as clinical research and forensic toxicology. The new Thermo Scientific TSQ Altis Triple Stage Quadrupole mass spectrometer... Read more

June 5, 2017 Lab Top-10 Licensing, IP, and Legal M&A, Partnerships

Shimadzu Corporation and Phytronix Technologies sign an agreement to offer the first Triple Ion Source (LDTD-MS/MS, ESI-MS/MS and APCI-MS/MS).

Kyoto, Japan and Québec, Canada – June 5, 2017. Shimadzu, one of the world’s fastest growing mass spectrometry companies, and Phytronix, world leader in high throughput analysis in mass spectrometry, announce today that they have signed an agreement to offer the industry’s first Triple Ion Source. Ideal for both screening and confirmation work, this new... Read more